A federal judge on Monday temporarily blocked the U.S. administration’s planned 340B Rebate Model Pilot Program, finding that regulators likely failed to meet basic administrative law requirements ...

I am a proud health care professional here in Delaware, and I am calling on leaders in Washington, D.C. to support the 340B ACCESS Act. This legislation is urgently needed to restore accountability to ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

The Trump administration has approved eight drugmakers' rebate plans for a controversial 340B drug discount pilot program that kicks off Jan. 1. The 340B Rebate Model Pilot Program, unveiled this ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Federal regulators have greenlit eight drugmaker ...

The Health Resources and Services Administration has approved eight manufacturer rebate plans under a new 340B pilot program set to launch Jan. 1. The initiative will replace upfront drug discounts ...

Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the Health, Education, Labor and Pensions Committee appear to agree that ...

In July, the Health Resources and Services Administration announced the availability of a voluntary 340B Rebate Model Pilot Program. The program is voluntary for drugmakers, but not for hospitals, ...

The anticipated burdens on hospitals to comply with the Health Resources and Services Administration's 340B Rebate Pilot Program far exceed the agency's estimates, and HRSA should delay the program's ...

A U.S. federal judge has rejected challenges by two pharmaceutical manufacturers seeking to block a Maine law that regulates the use of contract pharmacies under the federal 340B drug discount program ...

The 340B drug discount program has followed a familiar health policy trajectory. An intervention that was supposed to ease cost pressures, it instead is producing cascading unintended consequences ...